Kikuchi-Fujimoto Disease, A Possible Complication of Rituximab Treatment |
Lee, Jiwon
(Department of Pediatrics, Seoul National University Children's Hospital)
Chang, Hye Jin (Department of Pediatrics, Seoul National University Children's Hospital) Lee, Sang Taek (Department of Pediatrics, Seoul National University Children's Hospital) Kang, Hee Gyung (Department of Pediatrics, Seoul National University Children's Hospital) Ha, Il Soo (Department of Pediatrics, Seoul National University Children's Hospital) Cheong, Hae Il (Department of Pediatrics, Seoul National University Children's Hospital) |
1 | Iijima K. Rituximab for childhood refractory nephrotic syndrome. Pediatr. Int 2011;53:617-21. DOI ScienceOn |
2 | Liote H, Liote F, Seroussi B, Mayaud C, Cadranel J. Rituximabinduced lung disease: a systematic literature review. Eur Respir J 2010;35:681-7. DOI ScienceOn |
3 | Ardelean DS, Gonska T, Wires S, Cutz E, Griffiths A, Harvey E, Tse SM, Benseler SM. Severe ulcerative colitis after rituximab therapy. Pediatrics 2010;126:e243-e6. DOI |
4 | Parajuli R, Hire E, Shah BK. Rituximab-induced acute severe thrombocytopenia. Br J Haematol 2010;149:804. DOI ScienceOn |
5 | Hutchinson CB, Wang E. Kikuchi-Fujimoto disease. Arch Pathol Lab Med 2010;134:289-93. |
6 | Lee BC, Patel R. Kikuchi-Fujimoto disease: a 15-year analysis at a children's hospital in the United States. Clin Pediatr (Philadelphia) 2012 Feb 7 [Epub ahead of print] |
7 | Kwon SY, Kim TK, Kim YS, Lee KY, Lee NJ, Seol HY. CT findings in Kikuchi disease: analysis of 96 cases. AJNR Am J Neuroradiol 2004;25:1099-102. |
8 | Lee S, Yoo JH, Lee SW. Kikuchi disease: differentiation from tuberculous lymphadenitis based on patterns of nodal necrosis on CT. AJNR Am J Neuroradiol 2012;33:135-40. DOI ScienceOn |
9 | Stasi R, Del Poeta G, Stipa E, Evangelista ML, Trawinska MM, Cooper N, Amadori S. Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura. Blood 2007;110:2924-30. DOI ScienceOn |
10 | Kimby E. Tolerability and safety of rituximab (MabThera). Cancer Treat Rev 2005;31:456-73. DOI ScienceOn |
11 | Liossis SN, Sfikakis PP. Rituximab-induced B cell depletion in autoimmune diseases: potential effects on T cells. Clin Immunol 2008;127:280-5. DOI ScienceOn |